Ex-Texas hospital president pleads guilty to conspiracy

Syed Rizwan Mohiuddin, former president of United Memorial Medical Center in Houston, has pleaded guilty to a charge of conspiracy to defraud the federal government, according to the Houston Chronicle.

Advertisement

The charge comes from a 2010 business deal and carries a maximum sentence of five years in prison and a fine of $250,000, according to the report. It does not appear to be connected to his role at the hospital. 

In 2018, Mr. Mohiuddin pleaded not guilty to a five-charge indictment related to conspiracy, wire fraud, bank fraud and monetary transactions in criminally derived property. Prosecutors plan to drop the remaining four charges as part of a plea agreement, according to the Chronicle

A sentencing hearing for Mr. Mohiuddin will be held at a later date.

The hospital that he oversaw, United Memorial Medical Center, was in the process of being sold in July. It recently shut down much of its clinical work after losing Medicare and Medicaid funding for alleged cleanliness and safety issues, according to Fox26 Houston

The hospital is also facing lawsuits from multiple plaintiffs, including two emergency room physicians who alleged in an August lawsuit that the hospital did not pay them for their work, according to the Chronicle.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-MetrixPaul Summers, Nevada Heart & Vascular

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.